Knowledge, attitudes, and communication around human papillomavirus (HPV) vaccination amongst urban Asian mothers and physicians

Vaccine

Volumn 28, Issue 22, 2010, Pages 3809-3817

  Chow, Song Nan ^a,b   Soon, Ruey ^c   Park, Jong Sup ^d   Pancharoen, Chitsanu ^e   Qiao, You Lin ^f   Basu, Partha ^g   Ngan, Hextan Yuen Sheung ^h  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b MIN SHENG GENERAL HOSPITAL   (Taiwan)

^c Sabah Women and Children's Hospital   (Malaysia)

^d The Catholic University of Korea   (South Korea)

^e KING CHULALONGKORN MEMORIAL HOSPITAL   (Thailand)

^f CANCER HOSPITAL   (China)

^g CHITTARANJAN NATIONAL CANCER INSTITUTE   (India)

^h UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Barriers to uptake; HPV vaccination; Survey

Indexed keywords

WART VIRUS VACCINE;

ADULT; ARTICLE; ASIAN; CONTROLLED STUDY; DESCRIPTIVE RESEARCH; DOCTOR PATIENT RELATION; FEMALE; HEALTH EDUCATION; HEALTH SURVEY; HELP SEEKING BEHAVIOR; HUMAN; KOREA; MALAYSIA; MATERNAL ATTITUDE; OBSERVATIONAL STUDY; PHYSICIAN ATTITUDE; PREVENTIVE MEDICINE; PRIORITY JOURNAL; TAIWAN; THAILAND; URBAN POPULATION; UTERINE CERVIX CANCER; WART VIRUS;

ASIAN CONTINENTAL ANCESTRY GROUP; COMMUNICATION; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALAYSIA; MOTHERS; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PHYSICIAN-PATIENT RELATIONS; PHYSICIANS; REPUBLIC OF KOREA; TAIWAN; THAILAND; URBAN POPULATION; UTERINE CERVICAL NEOPLASMS;

EID: 77952551778     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.03.027     Document Type: Article

References (24)

1. Ferlay J., Bray P., Pizani P., and Parkin DM. GLOBOCAN 2002: Cancer incidence, mortality and prevalence worldwide (2004), IARC Press, Lyon. http://www-dep.iarc.fr
2. Bosch F.X., Lorincz A., Munoz N., Meijer C.J., and Shah K.V. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 55 4 (2002) 244-265
3. Bosch F.X., Burchell A.N., Schiffman M., Giuliano A.R., de Sanjose S., Bruni L., et al. Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia. Vaccine 26S (2008) K1-K16
4. Baseman J.G., and Koutsky L.A. The epidemiology of human papillomavirus infections. J Clin Virol 32 Suppl. 1 (2005) S16-24
5. Brown D.R., Shew M.L., Qadadri B., Neptune N., Vargas M., Tu W., et al. A longitudinal study of genital human papillomavirus infection in a cohort of closely followed adolescent women. J Infect Dis 191 2 (2005) 182-192
6. Castellsague X., Schneider A., Kaufmann A.M., and Bosch F.X. HPV vaccination against cervical cancer in women above 25 years of age: key considerations and current perspectives. Gynecol Oncol 115 3 Suppl. (2009) S15-23
7. Harper D.M., Franco E.L., Wheeler C.M., Moscicki A.B., Romanowski B., Roteli-Martins C.M., et al. Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial. Lancet 367 9518 (2006) 1247-1255
8. Joura E.A., Leodolter S., Hernandez-Avila M., Wheeler C.M., Perez G., Koutsky L.A., et al. Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials. Lancet 369 9574 (2007) 1693-1702
9. GlaxoSmithKline Biologicals. Data on file; 2008.
10. Tay S.K., Ngan H.Y., Chu T.Y., Cheung A.N., and Tay E.H. Epidemiology of human papillomavirus infection and cervical cancer and future perspectives in Hong Kong, Singapore and Taiwan. Vaccine 26 Suppl. 12 (2008) M60-70
11. Human papillomavirus WHO position paper. Wkly Epidemiol Rec 84 15 (2009) 117-132
12. Wong L.P. Young multiethnic women's attitudes toward the HPV vaccine and HPV vaccination. Int J Gynaecol Obstet 103 2 (2008) 131-135
13. Kwan T.T., Chan K.K., Yip A.M., Tam K.F., Cheung A.N., Young P.M., et al. Barriers and facilitators to human papillomavirus vaccination among Chinese adolescent girls in Hong Kong: a qualitative-quantitative study. Sex Transm Infect 84 3 (2008) 227-232
14. Zimet G.D. Understanding and overcoming barriers to human papillomavirus vaccine acceptance. Curr Opin Obstet Gynecol 18 Suppl. 1 (2006) s23-s28
15. Wong L.P. HPV information needs, educational messages and channel of delivery preferences: views from developing country with multiethnic populations. Vaccine 27 9 (2009) 1410-1415
16. Black L.L., Zimet G.D., Short M.B., Sturm L., and Rosenthal S.L. Literature review of human papillomavirus vaccine acceptability among women over 26 years. Vaccine 27 11 (2009) 1668-1673
17. Garland S., Park S.N., Ngan H.Y., Frazer I., Tay E.H., Chen C.J., et al. The need for public education on HPV and cervical cancer prevention in Asia. Opinions of experts at the AOGIN conference. Vaccine 26 43 (2008) 5435-5440
18. Pitts M.K., Dyson S.J., Rosenthal D.A., and Garland S.M. Knowledge and awareness of human papillomavirus (HPV): attitudes towards HPV vaccination among a representative sample of women in Victoria, Australia. Sex Health 4 3 (2007) 177-180
19. Lee P.W., Kwan T.T., Tam K.F., Chan K.K., Young P.M., Lo S.S., et al. Beliefs about cervical cancer and human papillomavirus (HPV) and acceptability of HPV vaccination among Chinese women in Hong Kong. Prev Med 45 2-3 (2007) 130-134
20. Bingham A., Drake J.K., and LaMontagne D.S. Sociocultural issues in the introduction of human papillomavirus vaccine in low-resource settings. Arch Pediatr Adolesc Med 163 5 (2009) 455-461
21. Pitts M., Smith A., Croy S., Lyons A., Ryall R., Garland S., et al. Singaporean men's knowledge of cervical cancer and human papillomavirus (HPV) and their attitudes towards HPV vaccination. Vaccine 27 22 (2009) 2989-2993
22. Katz M.L., Reiter P.L., Heaner S., Ruffin M.T., Post D.M., and Paskett E.D. Acceptance of the HPV vaccine among women, parents, community leaders, and healthcare providers in Ohio Appalachia. Vaccine 27 30 (2009) 3945-3952
23. Wong L.P. Physicians' experiences with HPV vaccine delivery: evidence from developing country with multiethnic populations. Vaccine 27 10 (2009) 1622-1627
24. Harries J., Moodley J., Barone M.A., Mall S., and Sinanovic E. Preparing for HPV vaccination in South Africa: key challenges and opinions. Vaccine 27 1 (2009) 38-44